Double-blind Comparative Study of TAK-875.
Phase of Trial: Phase III
Latest Information Update: 23 May 2016
At a glance
- Drugs Fasiglifam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Takeda
- 07 Jun 2017 Biomarkers information updated
- 24 Sep 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 24 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History